Mera Pharmaceuticals Valuation
| MRPI Stock | USD 0.0001 0.00 0.00% |
Mera Pharmaceuticals seems to be overvalued based on Macroaxis valuation methodology. Our model forecasts the value of Mera Pharmaceuticals from analyzing the firm fundamentals such as Revenue of 302.62 K, return on asset of -1.74, and Shares Outstanding of 557.3 M as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Mera Pharmaceuticals' price fluctuation is very steady at this time. Calculation of the real value of Mera Pharmaceuticals is based on 3 months time horizon. Increasing Mera Pharmaceuticals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Mera Pharmaceuticals is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Mera Pink Sheet. However, Mera Pharmaceuticals' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.0E-4 | Real 8.4E-5 | Hype 1.0E-4 |
The intrinsic value of Mera Pharmaceuticals' stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Mera Pharmaceuticals' stock price.
Estimating the potential upside or downside of Mera Pharmaceuticals helps investors to forecast how Mera pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Mera Pharmaceuticals more accurately as focusing exclusively on Mera Pharmaceuticals' fundamentals will not take into account other important factors: About Mera Pharmaceuticals Valuation
An absolute valuation paradigm, as applied to Mera Pink Sheet, attempts to find the value of Mera Pharmaceuticals based on its fundamental and basic technical indicators. By analyzing Mera Pharmaceuticals's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Mera Pharmaceuticals's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Mera Pharmaceuticals. We calculate exposure to Mera Pharmaceuticals's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Mera Pharmaceuticals's related companies.Mera Pharmaceuticals, Inc. focuses on the development and commercialization of natural products from microalgae using its proprietary and large-scale photobioreactor technology. Mera Pharmaceuticals, Inc. was founded in 1983 and is based in Las Vegas, Nevada. Mera Pharma is traded on OTC Exchange in the United States.
8 Steps to conduct Mera Pharmaceuticals' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Mera Pharmaceuticals' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Mera Pharmaceuticals' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Mera Pharmaceuticals' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Mera Pharmaceuticals' revenue streams: Identify Mera Pharmaceuticals' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Mera Pharmaceuticals' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Mera Pharmaceuticals' growth potential: Evaluate Mera Pharmaceuticals' management, business model, and growth potential.
- Determine Mera Pharmaceuticals' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Mera Pharmaceuticals' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Mera Pharmaceuticals Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Retained Earnings | -8.5 M | |
| Quarterly Revenue Growth Y O Y | -0.004 |
Complementary Tools for Mera Pink Sheet analysis
When running Mera Pharmaceuticals' price analysis, check to measure Mera Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mera Pharmaceuticals is operating at the current time. Most of Mera Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Mera Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mera Pharmaceuticals' price. Additionally, you may evaluate how the addition of Mera Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |